Synthese von 5-Methyl-3-oxa-A-nor-5β-cholestan und 3-Oxa-Δ4-cholesten-2-on

2, 3-seco-Δ⁴-Cholestene-2, 3-dicarboxylic acid ( 5 ) was prepared in 30% yield from 2-hydroxymethylene-Δ⁴-cholestene-3-one ( 1 ) by ozonolysis under special conditions. Pyrolysis of the pure di-acid 5 gave A-nor-Δ³⁽⁵⁾-cholestene-2-one ( 6 ), the anhydride 2 and 5-methyl-3-oxa-A-nor-5β-cholestane-2-one ( 8 ). Pyrolysis of amorphous acidic material obtained by the ozonolysis of 1 yielded the enol-lactones 7 and 9 as additional products. LiA1H₄-reduction of the γ-lactone 8 gave the diol 10 , which was transformed into 5-methyl-3-oxa-A-nor-5β-cholestane ( 13 ) by treatment with tosyl chloride in pyridine.     

Oxetane from A-nor-steroides: 2-alpha, 5-oxido-A-nor-5-alpha-cholestane, 2-beta, 5-oxido-A-nor-5-beta-cholestane and 2-alpha-ethyl-2-beta,2'-oxido-A-nor-5-alpha-cholestane

Treatment of 2β-tosyloxy-A-nor-5α-cholestane-5-ol ( 2 ) with t-butoxide in t-butanol gave 2α, 5-epoxy-A-nor-5α-cholestane ( 3 ) in quantitative yield. When A-nor-5β-cholestane-2α, 5-diol ( 4 ) was treated with tosyl chloride in pyridine 2β-chloro-A-nor-5β-cholestane-5-ol ( 7 ) and 2α-tosyloxy-A-nor-5β-cholestane-5-ol ( 8 ) were obtained. Whereas the chloride 7 was resistant to t-butoxide the tosylate 8 was transformed into an 1 : 1 mixture of 2α, 5-epoxy-5β-cholestane ( 10 ) and 2ξ-t-butoxy-A-nor-5β-cholestane-5-ol ( 11 ). In 2α-tosyloxy-A-nor-5α-cholestane-5-ol ( 12 ) substitution occurred as the only reaction. Both oxetanes 3 and 10 isomerize after heating above 50° and in polar or protic solvents to form A-nor-Δ³⁽⁵⁾-cholestene-2α-ol ( 6 ) and -2β-ol ( 14 ) respectively. Also, 2, 5-diols are encountered. 2α-Ethyl-2β, 2′-epoxy-A-nor-5α-cholestane ( 23 ) was synthesized starting from A-nor-5α-cholestane-2-one ( 17 ). The intermediates were the ester 16 , the diol 18 , the hydroxy-tosylate 19 and the chlorhydrin 20 . The spirocyclic oxetane 23 was reduced by LiAlH₄ in dioxane (not in ether). By chromatography on silica gel 23 was isomerized to the homoallylic alcohol 21 and transformed into 2-methylene-A-nor-5α-cholestane ( 24 ) by fragmentation. The IR. and NMR. spectra of the new oxetanes were compared with those of a series of known oxetanes.     

20, 21-Azirdin-Steroide: Reaktion von Derivaten der Oxime von 5-Pregnen-20-on,9β,10α-5-Pregnen-20-on und 9β,10α-5,7-Pregnadien-20-on mit Lithiumaluminiumhydrid und von 3β-Hydroxy-5-pregnen-20-on-oxim mit Grignard-Verbindungen

20, 21-Aziridine Steroids: Reaction of Derivatives of the Oximes of 5-Pregnen-20-one, 9β, 10α-5-Pregnen-20-one and 9β, 10α-5,7-Pregnadiene-20-one with Lithium Aluminium Hydride, and of 3β-Hydroxy-5-pregnen-20-one Oxime with Grignard Reagents. Reduction of 3β-hydroxy-5-pregnen-20-one oxime ( 2 ) with LiAlH₄ in tetrahydrofuran yielded 20α-amino-5-pregnen-3β-ol ( 1 ), 20β-amino-5-pregnen-3β-ol ( 3 ), 20β, 21-imino-5-pregnen-3β-ol ( 6 ) and 20β, 21-imino-5-pregnen-3β-ol ( 9 ). The aziridines 6 and 9 were separated via the acetyl derivatives 7 and 10 . The reaction of 6 and 9 with CS₂ gave 5-(3β-hydroxy-5-androsten-17β-yl)-thiazolidine-2-thione ( 8 ). Treatment of the 20-oximes 12 and 15 of the corresponding 9β,10α(retro)-pregnane derivatives with LiAlH₄ gave the aziridines 13 and 16 , respectively. Their deamination led to the diene 14 and triene 17 , respectively. Reduction of isobutyl methyl ketone-oxime with LiAlH₄ in tetrahydrofuran yielded 2-amino-4-methyl-pentane ( 19 ) as main product, 1, 2-imino-4-methyl-pentane ( 22 ) as second product and the epimeric 2,3-imino-4-methyl-pentanes 20 and 21 as minor products. – 3β-Hydroxy-5-pregnen-20-one oxime ( 2 ) was transformed by methylmagnesium iodide in toluene to 20α, 21-imino-20-methyl-5-pregnen-3β-ol ( 23 ) and 20β, 21-imino-20-methyl-5-pregnen-3β-ol ( 26 ). Acetylation of these aziridines was accompanied by elimination reactions leading to 3β-acetoxy-20-methylidene-21-N-acetylamino-5-pregnene ( 30 ) and 3β-acetoxy-20-methyl-21-N-acetylamino-5,17-pregnadiene ( 32 ). The reaction of oxime 2 with ethylmagnesium bromide in toluene gave 20α, 21-imino-20-ethyl-5-pregnen-3β-ol ( 24 ) and 20α,21-imino-20-ethyl-5-pregnen-3β-ol ( 27 ). Acetylation of 24 and 27 led to 3β-acetoxy-20-ethylidene-21-N-acetylamino-5-pregnene ( 31 ), 3β-acetoxy-20-ethyl-21-N-acetylamino-5,17-pregnadiene 33 and 3β, 20-diacetoxy-20-ethyl-21-N-acetylamino-5-pregnene ( 37 ). With phenylmagnesium bromide in toluene the oxime 2 was transformed to 20β, 21-imino-20-phenyl-5-pregnen-3β-ol ( 25 ) and 20β,21-imino-20-phenyl-5-pregnen-3β-ol ( 28 ). Acetylation of 25 and 28 yielded 3β-acetoxy-20-phenyl-21-N-acetylamino-5, 17-pregnadiene ( 34 ) and 3β,20-diacetoxy-20-phenyl-21-N-acetylamino-5-pregnene ( 39 ). LiAlH₄-reduction of 39 gave 3β, 20-dihydroxy-20-phenyl-21-N-ethylamino-5-pregnene ( 41 ). – The 20, 21-aziridines are stable to LiAlH₄. Consequently they are no intermediates in the formation of the 20-amino derivatives obtained from the oxime 2 .     

Lewis acid-catalyzed rearrangement of steroidal oxetanes: revision of the course of solvolysis of 3β-tosyloxy-5β-cholestan-5-ol-6-one.

The BF₃-catalysed rearrangement of 6β-acetoxy-3α,5-epoxy-5α-cholestane gave the 3α,5β-diol, the 3α,10α-epoxide, and the 2α,5α-epoxide, and the product of solvolysis of 3β-tosyloxy-5β-cholestan-5-ol-6-one was identified as 3α,5-epoxy-A-homo-B-nor-5α-cholestan-4a-one.     

Synthesis of 2,5 diol of A-nor-5 alpha-androstan-17 beta- ols and A-nor-5 beta-androstan-17 beta-ols

The synthesis of A-nor-5β-androstane-2α,5,17β-triol ( 8 ), A-nor-5β-androstane-2β,5,17β-triol ( 10 ), A-nor-5α-androstane-2β,5,17β-triol ( 20 ), A-nor-5α-androstane-2β,5,17β-triol ( 22 ) and of their 17-O-benzoyl derivatives is described, using A-nor-testosterone ( 1 ) as starting material.     

Synthese von 3-Oxacholestanen

Successive treatment of 5α-cholestan-3-one ( 1 ) with O₂ under basic conditions and then NaBH₄ led to 5α-3-oxa-cholestan-2-one ( 5 ). Analogous reactions with 5β-cholestan-3-one ( 6 ) yielded 5α-4-oxa-cholestan-3-one ( 7 ) and 5 ξ-3-oxa-cholestan-4-one ( 8 ). 4-Cholesten-2-one ( 10 ), which was prepared starting from 4-cholesten-3-one, was isomerized by methanolic KOH to give a mixture of 5α-cholest-3-en-2-one ( 11 ) and 5β-cholest-3-en-2-one ( 12 ). 5β-Cholestane-2,3-dione ( 17 ) was synthesized from 4β-bromo-5β-cholestan-3-one ( 13 ). Ozonolysis of the dione 17 and subsequent NaBH₄ reduction of the oxidation product gave both 5β-2-oxa-cholestan-3-one ( 18 ) and 5β-3-oxa-cholestan-2-one ( 19 ).     

IBX in an ionic liquid: eco-friendly oxidation of 17α-methylandrostan-3β,17β-diol, an intermediate in the synthesis of anabolic oxandrolone

An easily available hypervalent iodine(V) reagent, 2-iodoxybenzoic acid (IBX) immobilized in the ionic liquid [bmim][Br] was found to be an efficient and eco-friendly protocol for the oxidation of 17α-methylandrostan-3β,17β-diol (1). At ambient temperature oxidation of 1 with IBX gave mestanolone (2) in good yield and with an increased stoichiometric amount of IBX, oxidation adjacent to the carbonyl functionality (α,β-unsaturation) occurred to give dehydrogenated 17β-hydroxy-17α-methyl-Δ¹-androsten-3-one (3) as the major product in a one-pot reaction. The product is easily obtained by extraction with diethyl ether and evaporation of the solvent.     

Conformations of the Ten-membered Ring in 5, 10-Secosteroids. III: (Z)-3β- and (Z)-3α-Hydroxy-5, 10-seco-1 (10)-cholesten-5-one Esters and (Z)-5, 10-seco-1 (10)-Cholestene-3, 5-dione

(Z)-3β-Acetoxy- and (Z)-3 α-acetoxy-5, 10-seco-1 (10)-cholesten-5-one ( 6a ) and ( 7a ) were synthesized by fragmentation of 3β-acetoxy-5α-cholestan-5-ol ( 1 ) and 3α-acetoxy-5β-cholestan-5-ol ( 2 ), respectively, using in both cases the hypoiodite reaction (the lead tetraacetate/iodine version). The 3β-acetate 6a was further transformed, via the 3β-alcohol 6d to the corresponding (Z)-3β-p-bromobenzoate ester 6b and to (Z)-5, 10-seco-1 (10)-cholestene-3, 5-dione ( 8 ) (also obtainable from the 3α-acetate 7a ). The ¹H-and ¹³C-NMR. spectra showed that the (Z)-unsaturated 10-membered ring in all three compounds ( 6a , 7a and 8 ) exists in toluene, in only one conformation of type C ₁, the same as that of the (Z)-3β-p-bromobenzoate 6b in the solid state found by X-ray analysis. The unfavourable relative spatial factors (interdistance and mutual orientation) of the active centres in conformations of type C ₁ are responsible for the absence of intramolecular cyclizations in the (Z)-ketoesters 6 and 7 ( a and c ).     

Dissimilar behaviour of 3β, 16α-dihydroxy-5α-androstan-17-one Diacetate under Basic and Acidic Conditions

The base-catalysed rearrangement of 3β, 16α-dihydroxy-5α-androstan-17-one diacetate ( 1 ) in (D₆)benzene/ CD₃OD to 3β, 17β-dihydroxy-5α-androstan-16-one ( 3 ) is followed by ¹³C-NMR spectroscopy. By the same procedure, it is determined that in (D₆)benzene/CD₃OD, but under acid catalysis, 1 does not rearrange to 3 but yields the intermediate product 3β, 16α-dihydroxy-5α -androstan-17-one 17α -methyl hemiacetal ( 5 ).     

Stereoselective ring-opening reactions with AcBr and AcCl. A new method for preparation of some haloconduritols

The actions of AcX (X=Br, Cl) on 7-oxa-bicyclo[2.2.1]hept-5-ene-2,3-diol diacetates and a transoid-epoxide prepared from the acetonide of cyclohexa-3,5-diene-cis-1,2-diol were studied. H₂SO₄-catalyzed cleavage of exo-cis-7-oxa-bicyclo[2.2.1]hept-5-ene-2,3-diol diacetate with AcCl gave (1α,2α,3α,6β)-6-chloro-4-cyclohexene-1,2,3-triol triacetate, from which the corresponding chloroconduritol was obtained by trans-esterification (MeOH/HCl). A similar reaction of the exo-diacetate with AcBr in the presence of H₂SO₄ resulted in bromine addition. The formation of bromine from the reaction of AcBr and H₂SO₄ was observed by independent experiments. H₂SO₄-catalyzed reaction of endo-cis-7-oxa-bicyclo[2.2.1]hept-5-ene-2,3-diol diacetate with AcX (X=Br, Cl) gave (1α,2α,3β,6β)-6-halo-4-cyclohexene-1,2,3-triol triacetates. The reaction of the transoid-epoxide with AcX (X=Br, Cl) with no catalyst gave also (1α,2α,3β,6β)-6-halo-4-cyclohexene-1,2,3-triol triacetates.     

Viminolon,Strukturbeweis. Glykoside und Aglykone, 315. Mitteilung

Reduction of di-O-benzoyl-viminolon ( 1 ) with LiAlH₄ gave a mixture of 17-isopregn-5-ene-heptols. Treatment of this mixture with NaIO₄ produced the amorphous 12-O-formyl sarcostinketone (= 12-O-formyl-3β, 8β, 12β, 14β-tetrahydroxy androst-5-en-20-one) ( 4 ). This together with former results proves the structure of 1 .     

Synthesis of (-)-11 Hydroxy-delta8-6a, 10a-trans-tetrahydrocannabinol

When (?)-Δ⁸-6a, 10a-trans-THC (THC = Tetrahydrocannabinol), in the form of its diacetate, was irradiated in the presence of oxygen and a sensitizer, followed by reduction with NaBH₄, three allylic alcohols were formed: (?)-8α-and (?)-8β-hydroxy-Δ^9,11-THC (proportion 3:1) and (?)-9α-hydroxy-Δ^7,8-THC. Acetylation of the epimeric 8-hydroxy-compounds with Ac₂O/pyridine gave the corresponding diacetates. When (?)-Δ⁸-6a, 10a-trans-THC, in the form of its tetrahydropyranyl derivative, was heated with m-chloroperbenzoic acid, the two epimeric 8,9-epoxides were formed in equal amounts. These compounds, on treatment with butyllithium, afforded (?)-8α- and (?)-8β-hydroxy-Δ^9,11- 6a, 10a-trans-THC-tetrahydropyranylether. After removing the protecting group and treatment with Ac₂O/pyridine the same diacetates, as formed by photooxygenation of (?)-Δ⁸-THC-acetate, were obtained as a 1:1-mixture. On heating these epimeric diacetates to 290° they underwent allylic rearrangement to (?)-11-acetoxy-Δ⁸-THC-acetate. From this (?)-11-hydroxy-Δ⁸-6a, 10a-trans-THC was obtained by treatment with LiAlH₄.     

Steroids and sex hormones, 231. The synthesis of N-acetyl-3-aza-A-homo-5-beta, 10-alpha-andostran and its 5-alpha-isomers

A synthesis of N-acetyl-3-aza-A-homo-5β, 10α-androstane ( 14 ) and N-acetyl-3-aza-A-homo-5α, 10α-androstane ( 15 ) is described, starting from 2-oxo-17β-acetoxy-Δ⁵-10α-androstane ( 4 ).     

Metabolic studies of mesterolone in horses

Mesterolone (1α-methyl-5α-androstan-17β-ol-3-one) is a synthetic anabolic androgenic steroid (AAS) with reported abuses in human sports. As for other AAS, mesterolone is also a potential doping agent in equine sports. Metabolic studies on mesterolone have been reported for humans, whereas little is known about its metabolic fate in horses. This paper describes the studies of both the in vitro and in vivo metabolism of mesterolone in racehorses with an objective to identify the most appropriate target metabolites for detecting mesterolone administration.In vitro biotransformation studies of mesterolone were performed by incubating the steroid with horse liver microsomes. Metabolites in the incubation mixture were isolated by liquid-liquid extraction and analysed by gas chromatography-mass spectrometry (GC-MS) after acylation or silylation. Five metabolites (M1-M5) were detected. They were 1α-methyl-5α-androstan-3α-ol-17-one (M1), 1α-methyl-5α-androstan-3β-ol-17-one (M2), 1α-methyl-5α-androstane-3α,17β-diol (M3), 1α-methyl-5α-androstane-3β,17β-diol (M4), and 1α-methyl-5α-androstane-3,17-dione (M5). Of these in vitro metabolites, M1, M3, M4 and M5 were confirmed using authentic reference standards. M2 was tentatively identified by mass spectral comparison to M1.For the in vivo metabolic studies, Proviron^® (20 tablets × 25 mg of mesterolone) was administered orally to two thoroughbred geldings. Pre- and post-administration urine samples were collected for analysis. Free and conjugated metabolites were isolated using solid-phase extraction and analysed by GC-MS as described for the in vitro studies. The results revealed that mesterolone was extensively metabolised and the parent drug was not detected in urine. Three metabolites detected in the in vitro studies, namely M1, M2 and M4, were also detected in post-administration urine samples. In addition, two stereoisomers each of 1α-methyl-5α-androstane-3,17α-diol (M6 and M7) and 1α-methyl-5α-androstane-3,16-diol-17-one (M8 and M9), and an 18-hydroxylated metabolite 1α-methyl-5α-androstane-3,18-diol-17-one (M10) were also detected. The metabolic pathway for mesterolone is postulated. These studies have shown that metabolites M8, M9 and M10 could be used as potential screening targets for controlling the misuse of mesterolone in horses.     

Synthesis of 6-(α-thienyl)azulene from 2-butoxy-4-(α-thienyl)-Δ5-dihydropyran

2,5-Dibutoxy-4-(α-thienyl)-Δ³-dihydropyran was obtained by bromoalkoxylation at the double bond and dehydrobromination of 2-butoxy-4-(α-thienyl)-Δ⁵-dihydropyran. Acid hydrolysis of the product in the presence of N-methylaniline hydrochloride gave a salt of 3-(α-thienyl)glutaconic dialdehyde dianil, treatment of which with cyclopentadienylsodium in alcohol gives the corresponding fulvene, which is thermally cleaved to N-methylaniline and 6-(α-thienyl)azulene.     

Steroids and sex hormones. Quassinoid bitter principles. I. 1-oxo-2-methoxy-4 alpha-methyl-17 beta-hydroxy-delta2-5 alpha-androstene as a model for the ring a structure of quassine]

Starting from 3-oxo-17β-hydroxy-Δ¹-5α-androstene (2b) the preparation of 1-oxo-2-methoxy-4α-methyl-17β-hydroxy-Δ²-5α-androstene (9), a compound with the ring A structure of quassine (1) is described. The key problem of the reaction sequence is shown to be the monomethylation at C(4).     

On the synthesis of ecdysones

A synthesis of ecdysone is described by which the insect moulting hormone can be readily prepared. Oxidation of ergosterol gave the 6-keto-Δ⁷-function, and preparation of the Δ²-olefine followed by stereospecific hydroxylation led to the 2β,3β-glycol system. Ozonization furnished (20 S)-2β,3β-diacetoxy-20-formyl-5α-pregn-7-en-6-one into which the side chain was introduced by a Grignard reaction with 2-methyl-3-butyn-2-ol tetrahydropyran-2-yl ether and a subsequent reduction of the triple bond. Hydroxylation at C-14 and isomerization at C-5 gave ecdysone. By an interchange of the sequence of the reactions C-22 isoecdysone was obtained stereospecifically.     

Reactions of terpene alcohols and diols with chlorine dioxide in dimethylformamide

The system chlorine dioxide–dimethylformamide in combination with or without a catalytic amount of MoCl₅, CeCl₃, ZrOCl₂, or VO(acac)₂ induces oxidative chlorination of a number of bicyclic terpene alcohols and vicinal diols. 2α-Chloropinan-3-one, 3α-chloro-10β-pinan-4-one, 5α-chloro-3α-hydroxycaran-4-one, 5β-chloro-3β-hydroxycaran-4-one, and 4α-chloro-2α-hydroxypinan-3-one were thus synthesized in good preparative yields.     

Studies on the Constituents of Ganoderma Lucidum

The methanolic extract of fruit bodies of cultivated Ganoderma lucidum was separated by silica gel column chromatography and preparative thin-layer chromatography to give ten compounds. On the basis of spectral analysis, chemical procedures and gas chromatography, d-mannitol (1), ergosta-7, 22-dien-3β-yl palmitate (2), ergosterol (3), ergosta-7, 22-dien-3β-ol (4), 5α-lanosta-7,9(11),24-trien-3β,26-diol (5), ergosterol peroxide (6), 24,25,26-trihydroxy-5α-lanosta-7,9(11)-dien-3-one (7), 5α-lanosta-7,9(11)-dien-3β,24,25,26-tetraol (8) and 8,9-epoxyergosta-5,22-dien-3β,15-diol (9) were identified. Among these compounds, 8,9-epoxyergosta-5,22-dien-3β,15-diol was first separated from Ganoderma lucidum.     

Alcaloides stéroïdiques—CLXVI : Synthese d'azides tertiaires en serie alicyclique-II. Mechanisme de formation et isomerisation des azido-5α et 5β pregnanes

Treatment of 6β-hydroxy 5α -prégnane by N₃H/BF₃-etherate/benzene gave 5α and 5β-azido prégnanes with C₅→C₆ hydride transfer. The kinetic product was 5α-azido pregnane which epimerized into a thermodynamic mixture 5α-azido rlarr2; 5β-azido. N₃H Assistance was necessary for epimerization. Chemical degradation and ¹³C NMR study supported these structural assignments.